Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: Links with diabetes and BMI loss after gastric bypass

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 3, 2014, Pages 898-907

  Abdennour, Meriem ^b   Reggio, Sophie ^b   Le Naour, Gilles ^b   Liu, Yuejun ^b   Poitou, Christine ^b   Aron Wisnewsky, Judith ^b   Charlotte, Frederic ^b   Bouillot, Jean Luc ^b   Torcivia, Adriana ^b   Sasso, Magali ^b   Miette, Veronique ^b   Zucker, Jean Daniel ^b   Bedossa, Pierre ^b   Tordjman, Joan ^a   Clement, Karine ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY FAT; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ELASTOGRAPHY; FEMALE; HOSPITAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; MUSCULOSKELETAL SYSTEM PARAMETERS; OBSERVATIONAL STUDY; PHENOTYPE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH BYPASS; TISSUE STIFFNESS; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; FIBROSIS; GASTRIC BYPASS; HUMANS; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY, MORBID; VIBRATION; WEIGHT LOSS;

EID: 84895816895     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3253     Document Type: Article

References (37)

1. Tsuneto A, Hida A, Sera N, et al. Fatty liver incidence and predictive variables. Hypertens Res. 2010;33:638-643.
2. Boza C, Riquelme A, Ibañez L, et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg. 2005;15:1148-1153. (Pubitemid 41390213)
3. Haentjens P, Massaad D, Reynaert H, et al. Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics. Acta Clin Belg. 2009;64:483-493.
4. Nigam P, Bhatt SP, Misra A, Vaidya M, Dasgupta J, Chadha DS. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India. PLoS One. 2013;8:e49286.
5. Coulon S, Francque S, Colle I, et al. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine. 2012;59:442-449.
6. Amarapurkar D, Kamani P, Patel N, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007; 6:161-163. (Pubitemid 350277193)
7. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395. (Pubitemid 39657013)
8. Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51:454-462.
9. Cancello R, Tordjman J, Poitou C, et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 2006;55:1554-1561. (Pubitemid 44324107)
10. Henegar C, Tordjman J, Achard V, et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008;9:R14.
11. Divoux A, Tordjman J, Lacasa D, et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes. 2010;59:2817-2825.
12. Strissel KJ, Stancheva Z, Miyoshi H, et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007;56: 2910-2918. (Pubitemid 350223625)
13. Sun K, Tordjman J, Clément K, Scherer PE. Fibrosis and adipose tissue dysfunction. Cell Metab. 2013;18:470-477.
14. Spencer M, Yao-Borengasser A, Unal R, et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab. 2010;299:E1016-E1027.
15. Tsigos C, Hainer V, Basdevant A, et al. Management of obesity in adults: European clinical practice guidelines. Obes Facts. 2008;1: 106-116.
16. Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54:2277-2286. (Pubitemid 41134253)
17. Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137: 532-540.
18. SjöströmL. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219-234.
19. 2: an integrative review of early studies. Obes Surg. 2010;20:776-790.
20. Witkamp RF. Current and future drug targets in weight management. Pharm Res. 2011;28:1792-1818.
21. Lampe JW, Navarro SL, Hullar MA, Shojaie A. Inter-individual differences in response to dietary intervention: integrating omics platforms towards personalised dietary recommendations. Proc Nutr Soc. 2013;72:207-218.
22. Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244:734-740. (Pubitemid 44629947)
23. Lanyon RI, Maxwell BM. Predictors of outcome after gastric bypass surgery. Obes Surg. 2007;17:321-328. (Pubitemid 46659291)
24. Lee YC, Liew PL, Lee WJ, et al. Prediction of successful weight reduction after laparoscopic adjustable gastric banding. Hepatogastroenterology. 2009;56:1222-1226.
25. Poitou C, Coupaye M, Laaban JP, et al. Serum amyloid A and obstructive sleep apnea syndrome before and after surgically-induced weight loss in morbidly obese subjects. Obes Surg. 2006;16:1475-1481. (Pubitemid 44759981)
26. Tordjman J, Poitou C, Hugol D, et al. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. J Hepatol. 2009;51: 354-362.
27. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321. (Pubitemid 40770284)
28. Perlemuter G, Naveau S, Belle-Croix F, et al. Independent and opposite associations of trunk fat and leg fat with liver enzyme levels. Liver Int. 2008;28:1381-1388.
29. Ciangura C, Bouillot JL, Lloret-Linares C, et al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity (Silver Spring). 2010;18:760-765.
30. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705-1713. (Pubitemid 38091720)
31. Genolini C, Falissard B. KmL: k-means for longitudinal data. Comp Stat. 2010;25:317-332.
32. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective. Biochim Biophys Acta. 2010;1801:338-349.
33. Odena G, Bataller R. Liver fibrogenesis: physiopathology [in Spanish]. Gastroenterol Hepatol. 2012;35(suppl 2):3-9.
34. Ricard-Blum S. The collagen family. Cold Spring Harb Perspect Biol. 2011;3:a004978.
35. Anderson EK, Gutierrez DA, Kennedy A, Hasty AH. Weight cycling increases T-cell accumulation in adipose tissue and impairs systemic glucose tolerance. Diabetes. 2013;62:3180-3188.
36. Haque AK, Gadre S, Taylor J, Haque SA, Freeman D, Duarte A. Pulmonary and cardiovascular complications of obesity: an autopsy study of 76 obese subjects. Arch Pathol Lab Med. 2008;132:1397-1404.
37. Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M. Metabolic syndrome and renal disease. Int J Cardiol. 2013;164: 141-150.